NO810795L - R fremgangsmaate for fremstilling av blodtrykkssenkende midle - Google Patents

R fremgangsmaate for fremstilling av blodtrykkssenkende midle

Info

Publication number
NO810795L
NO810795L NO810795A NO810795A NO810795L NO 810795 L NO810795 L NO 810795L NO 810795 A NO810795 A NO 810795A NO 810795 A NO810795 A NO 810795A NO 810795 L NO810795 L NO 810795L
Authority
NO
Norway
Prior art keywords
substancing
procedure
agent
manufacturing
blood pressure
Prior art date
Application number
NO810795A
Other languages
English (en)
Other versions
NO156695B (no
NO156695C (no
Inventor
James Walter Ryan
Alfred Chung
Original Assignee
Univ Miami
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Miami filed Critical Univ Miami
Publication of NO810795L publication Critical patent/NO810795L/no
Publication of NO156695B publication Critical patent/NO156695B/no
Publication of NO156695C publication Critical patent/NO156695C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C329/00Thiocarbonic acids; Halides, esters or anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO810795A 1980-03-10 1981-03-09 Analogifremgangsmaate for fremstilling av blodtrykkssenkende midler. NO156695C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12895380A 1980-03-10 1980-03-10
US15827880A 1980-06-10 1980-06-10
AU73631/81A AU7363181A (en) 1980-03-10 1981-07-31 Anti-ace peptide preparative methods

Publications (3)

Publication Number Publication Date
NO810795L true NO810795L (no) 1981-09-11
NO156695B NO156695B (no) 1987-07-27
NO156695C NO156695C (no) 1987-11-04

Family

ID=27156035

Family Applications (5)

Application Number Title Priority Date Filing Date
NO810795A NO156695C (no) 1980-03-10 1981-03-09 Analogifremgangsmaate for fremstilling av blodtrykkssenkende midler.
NO831114A NO831114L (no) 1980-03-10 1983-03-28 Fremgangsmaate for fremstilling av blodtrykkssenkende midler
NO831111A NO831111L (no) 1980-03-10 1983-03-28 Fremgangsmaate for fremstilling av blodtrykkssenkende midler.
NO831112A NO831112L (no) 1980-03-10 1983-03-28 Fremgangsmaate for fremstilling av blodtrykkssenkende midler
NO831113A NO831113L (no) 1980-03-10 1983-03-28 Fremgangsmaate for fremstilling av blodtrykkssenkende midler

Family Applications After (4)

Application Number Title Priority Date Filing Date
NO831114A NO831114L (no) 1980-03-10 1983-03-28 Fremgangsmaate for fremstilling av blodtrykkssenkende midler
NO831111A NO831111L (no) 1980-03-10 1983-03-28 Fremgangsmaate for fremstilling av blodtrykkssenkende midler.
NO831112A NO831112L (no) 1980-03-10 1983-03-28 Fremgangsmaate for fremstilling av blodtrykkssenkende midler
NO831113A NO831113L (no) 1980-03-10 1983-03-28 Fremgangsmaate for fremstilling av blodtrykkssenkende midler

Country Status (14)

Country Link
EP (1) EP0038117A1 (no)
JP (3) JPH0667903B2 (no)
KR (1) KR850001629B1 (no)
AU (1) AU7363181A (no)
CS (1) CS174581A2 (no)
DD (1) DD156805A5 (no)
DK (1) DK105981A (no)
ES (5) ES500254A0 (no)
FI (1) FI810725L (no)
GR (1) GR74795B (no)
NO (5) NO156695C (no)
PL (1) PL230076A1 (no)
PT (1) PT72635B (no)
SU (1) SU1567125A3 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056935B2 (en) 1995-06-07 2006-06-06 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
US5801187A (en) 1996-09-25 1998-09-01 Gpi-Nil Holdings, Inc. Heterocyclic esters and amides
CN111039838B (zh) * 2019-12-31 2022-04-05 杭州乐敦科技有限公司 一种3-乙酰巯基-2-甲基丙酸的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA802420B (en) * 1979-05-18 1981-04-29 Squibb & Sons Inc Aminoacyl derivatives of mercaptoacyl amino acids

Also Published As

Publication number Publication date
DK105981A (da) 1981-09-11
PT72635B (en) 1982-03-19
NO156695B (no) 1987-07-27
JPH0667902B2 (ja) 1994-08-31
NO831113L (no) 1981-09-11
ES8305698A1 (es) 1983-04-16
FI810725L (fi) 1981-09-11
ES500254A0 (es) 1983-04-16
ES519567A0 (es) 1984-03-16
EP0038117A1 (en) 1981-10-21
NO831111L (no) 1981-09-11
PL230076A1 (no) 1982-09-13
JPH01250344A (ja) 1989-10-05
CS174581A2 (en) 1990-09-12
ES8403104A1 (es) 1984-03-01
JPH0667901B2 (ja) 1994-08-31
JPH02209865A (ja) 1990-08-21
JPH01246257A (ja) 1989-10-02
PT72635A (en) 1981-04-01
ES8403448A1 (es) 1984-03-16
ES519565A0 (es) 1984-03-16
JPH0667903B2 (ja) 1994-08-31
KR830005133A (ko) 1983-08-03
DD156805A5 (de) 1982-09-22
ES8403450A1 (es) 1984-03-16
ES519566A0 (es) 1984-03-16
ES8403449A1 (es) 1984-03-16
NO831112L (no) 1981-09-11
SU1567125A3 (ru) 1990-05-23
KR850001629B1 (ko) 1985-10-31
NO156695C (no) 1987-11-04
ES519564A0 (es) 1984-03-01
NO831114L (no) 1981-09-11
GR74795B (no) 1984-07-12
AU7363181A (en) 1983-02-03

Similar Documents

Publication Publication Date Title
SE8103535L (sv) Forfarande for framstellning av medeldestillat
NO152964C (no) Fremgangsmaate for fremstilling av mikrokapsler.
NO161118C (no) Fremgangsmaate for utvinning av for fysiologiske formaal direkte anvendbart ren-licithin.
NO156713B (no) Fremgangsmaate for fremstilling av antikariestyggegummi.
NO162158C (no) Fremgangsmaate for fremstilling av polyolefiner.
NO160655C (no) Fremgangsmaate til fremstilling av ammoniakk.
NO159667C (no) Fremgangsmaate for fremstilling av kikhostetoksid.
DK164674C (da) Blodgas-kontrolvaeske
NL187963C (nl) Chirurgische hechtdraad.
IT8225035A0 (it) Procedimento e apparecchiatura per la fabbricazione di legno compensato.
NO157860C (no) Framgangsmaate for framstilling av alkoholer.
NL182344C (nl) Drukverschilopnemer.
NO832803L (no) Fremgangsmaate for fremstilling av merkaptaner.
IT8122510A0 (it) Procedimento di fosfatazione.
NO822634L (no) Fremgangsmaate for fremstilling av cefemderivater.
NO810133L (no) Fremgangsmaate for fremstilling av et avfoeringsmiddel.
NO812519L (no) Fremgangsmaate for fremstilling av kolesterase.
NO157537C (no) Fremgangsmaate for fremstilling av tioetere.
NO812701L (no) Fremgangsmaate for fremstilling av antibakterielle timetyl-cefalosporiner.
NO810795L (no) R fremgangsmaate for fremstilling av blodtrykkssenkende midle
IT8122813A0 (it) Procedimento di preparazione di n-cicloesilbenzotiazol-2-solfenammi de.
NO812855L (no) Fremgangsmaate for fremstilling av urea.
NO155732C (no) Fremgangsmaate for fremstilling av kijanimicin.
IT8122146A0 (it) Procedimento per la produzione di mercapto-2-etanolo-1.
ES506814A0 (es) Procedimiento de preparacion de una 1-(trialcoxibencil)pi- perazina.